Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.925 USD | -10.88% | -19.79% | -18.43% |
Mar. 27 | Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
Mar. 27 | GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.43% | 139M | |
-3.46% | 102B | |
+1.83% | 96.07B | |
-1.80% | 21.66B | |
-17.62% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-27.65% | 13.79B | |
-0.83% | 13.33B | |
+19.37% | 10.94B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- GlycoMimetics : Roth Capital Adjusts GlycoMimetics' Price Target to $15 From $9, Reiterates Buy Rating